Weill Cornell Medicine researchers have discovered a mechanism that ovarian tumors use to cripple immune cells – blocking the energy supply T cells depend on. The work points toward a promising new immunotherapy approach for ovarian cancer.
A new system can accurately assess the chromosomal status of in vitro-fertilized embryos using only time-lapse video images of the embryos and maternal age, according to a study from investigators at Weill Cornell Medicine.
Investigators from Weill Cornell Medicine have discovered a defense mechanism that protects skin cancer cells from oxidative stress and helps them spread.
Angela Odoms-Young is the critical issue lead for extension programming in the areas of human nutrition, food safety and security and obesity prevention, effective October 1, 2024. The appointment reflects CCE's dedication to leveraging campus resources and CCE educators and collaborators across the state, to ensure that needs are met and key metrics and benchmarks for educational work are identified.
Professors Dr. Silvia Formenti and Dr. Massimo Loda have been elected to the National Academy of Medicine, in recognition of outstanding professional achievement and major contributions to the advancement of the medical sciences.
A study from Weill Cornell Medicine provides new insights into a pair of proteins and their opposing functions in regulating the interferon response in hepatic stellate cells, a critical immune component in the liver’s fight against tumors.
Interim President Michael I. Kotlikoff invoked history – Cornell’s and his own – in his first State of the University address, delivered Oct. 18 in Call Auditorium during the Trustee-Council Annual Meeting.
Cornell Tech today announced that longtime supporter and Cornell alumnus Frederic Rubinstein ’52, LLB ’55 has donated $1 million to the campus’ Public Interest Technology (PiTech) program to support research that helps to…
The findings could lead to new treatments targeting a particular protein to better manage inflammation in patients who don’t respond well to existing therapies.
